Skip to main content
. 2021 Sep 16;12:684545. doi: 10.3389/fphar.2021.684545

FIGURE 5.

FIGURE 5

PFS of patients with high and low expression of OCTN2 with negative lymph nodes treated with oxaliplatin. Kaplan -Meier progression-free survival curves in lymph node negative patients with low or high mRNA (A) or protein (B) expression of OCTN2. Samples with relative mRNA value or staining score ≥ of the median value were classified as OCTN2 high-expressing tumors.